Category: Press Release - Page 170 - Psychedelic Alpha

Explore our new Pα+ Psychedelic Bill Tracker.

Read more about the article Dr. John Fahy Joins Revive Therapeutics as Scientific and Clinical Advisor for COVID-19 FDA Phase 3 Study

Dr. John Fahy Joins Revive Therapeutics as Scientific and Clinical Advisor for COVID-19 FDA Phase 3 Study

Post published:December 31, 2020
Post category:Press Release

Read more about the article Mind Cure Announces Retail Roll Out of Nootropics Lineup Across North America with Body Energy Club

Mind Cure Announces Retail Roll Out of Nootropics Lineup Across North America with Body Energy Club

Post published:December 31, 2020
Post category:Press Release

Read more about the article BetterPlant Subsidiary NeonMind Closes Oversubscribed Initial Public Offering and Exercise in Full of the Agent’s Over-Allotment Option

BetterPlant Subsidiary NeonMind Closes Oversubscribed Initial Public Offering and Exercise in Full of the Agent’s Over-Allotment Option

Post published:December 31, 2020
Post category:Press Release

Read more about the article Legal Psychedelic Therapy Comes to Alberta With Ground-Breaking Health Canada Decision

Legal Psychedelic Therapy Comes to Alberta With Ground-Breaking Health Canada Decision

Post published:December 30, 2020
Post category:Press Release

Read more about the article Red Light Holland To Make Groundbreaking Investment in St. Vincent and the Grenadines’ Plant-Based Wellness and Psychedelics Industry

Red Light Holland To Make Groundbreaking Investment in St. Vincent and the Grenadines’ Plant-Based Wellness and Psychedelics Industry

Post published:December 30, 2020
Post category:Press Release

Read more about the article PharmaTher Announces Application for OTCQB Listing

PharmaTher Announces Application for OTCQB Listing

Post published:December 30, 2020
Post category:Press Release

Read more about the article Pure Extracts Commences Study on Psilocybin Oral Tablets, Capsules and Nasal Gel

Pure Extracts Commences Study on Psilocybin Oral Tablets, Capsules and Nasal Gel

Post published:December 30, 2020
Post category:Press Release

Read more about the article Numinus Announces Closing of $17 Million Bought Deal Offering Including Full Exercise of Over-Allotment Option

Numinus Announces Closing of $17 Million Bought Deal Offering Including Full Exercise of Over-Allotment Option

Post published:December 29, 2020
Post category:Press Release

Read more about the article Better Plant’s Subsidiary Neonmind to Complete Fully Subscribed IPO and Commence Trading on Monday, January 4, 2021 under the Symbol NEON

Better Plant’s Subsidiary Neonmind to Complete Fully Subscribed IPO and Commence Trading on Monday, January 4, 2021 under the Symbol NEON

Post published:December 29, 2020
Post category:Press Release

Read more about the article Mindset Further Expands Portfolio of Psychedelic Drug Candidates with Third U.S. Provisional Patent Application; 50 Total New Psychedelic Patent-Pending Compounds Synthesized

Mindset Further Expands Portfolio of Psychedelic Drug Candidates with Third U.S. Provisional Patent Application; 50 Total New Psychedelic Patent-Pending Compounds Synthesized

Post published:December 29, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.